🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Twelve adults with ALS will participate in a study involving four 3-week cy...
Status
Completed
Location
Duke University Medical Center
Start Date
2020-01-14
Trial ID
NCT04224961
Treatments Being Tested
The previous pilot study showed that two weeks of intensive expiratory musc...
Status
Recruiting
Location
General University Hospital
Start Date
2025-05-01
Trial ID
NCT06942533
Treatments Being Tested
Airway protective disorders, including swallowing (dysphagia) and cough (dy...
Status
Unknown
Location
General University Hospital
Start Date
2022-03-01
Trial ID
NCT05728099
The purpose of this study is to investigate the effects of two treatment te...
Status
Completed
Location
University of Florida
Start Date
2018-03-01
Trial ID
NCT03202017
Treatments Being Tested
A tele-health treatment study for individuals with early stage ALS with the...
Status
Completed
Location
Purdue University
Start Date
2021-01-01
Trial ID
NCT05003167
Treatments Being Tested
Postural abnormalities involving the trunk are prevalent in over 20% of pat...
Status
Not Yet Recruiting
Location
General University Hospital
Start Date
2025-08
Trial ID
NCT06963918
Treatments Being Tested
The goal of this clinical trial is to investigate the effects of a combined...
Status
Recruiting
Location
Hamad Medical Corporation
Start Date
2024-11-01
Trial ID
NCT06887855
This randomized clinical trial studies how well expiratory muscle strength ...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2016-09-29
Trial ID
NCT03175289
It was aimed to investigate the effect of expiratory muscle strength traini...
Status
Completed
Location
Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Start Date
2022-06-01
Trial ID
NCT05242406
Treatments Being Tested